Prof. Martin O'Halloran is a professor in medical electronics and a Science Foundation Ireland (SFI) Investigator at the University of Galway, Ireland. Reflecting the interdisciplinary nature of his research, he holds a joint affiliation with the College of Engineering and Informatics and the College of Medicine, Nursing & Health Sciences, and he leads the Translational Medical Device Laboratory at the Lambe Institute. Dr. O'Halloran has received over 30 national and international research awards and was recently awarded SFI's Early-Stage Researcher of the Year, Engineers Ireland Chartered Engineer of the Year, and the European Research Council's Starting Investigator Grant. He was a co-proposer of a European COST Action (entitled "MiMED") and is now leading a network of over 180 medical device researchers from 24 countries, focused on the clinical evaluation and commercialization of novel medical devices in Europe. Over the last 6 years, Dr. O'Halloran has personally secured EUR 5.6 million in direct research funding and has published more than 40 papers in peer-reviewed journals. Dr. O'Halloran has been an invited chair and invited speaker at several major electromagnetics and translational medicine conferences/seminars. He is currently a non-executive director of the BioInnovate program and co-lead of the Health Innovation Hub Ireland at NUI Galway.
Prof. Martin O'Halloran is a professor in medical electronics and a Science Foundation Ireland (SFI) Investigator at the University of Galway, Ireland. Reflecting the interdisciplinary nature of his research, he holds a joint affiliation with the College of Engineering and Informatics and the College of Medicine, Nursing & Health Sciences, and he leads the Translational Medical Device Laboratory at the Lambe Institute. Dr. O'Halloran has received over 30 national and international research awards and was recently awarded SFI's Early-Stage Researcher of the Year, Engineers Ireland Chartered Engineer of the Year, and the European Research Council's Starting Investigator Grant. He was a co-proposer of a European COST Action (entitled "MiMED") and is now leading a network of over 180 medical device researchers from 24 countries, focused on the clinical evaluation and commercialization of novel medical devices in Europe. Over the last 6 years, Dr. O'Halloran has personally secured EUR 5.6 million in direct research funding and has published more than 40 papers in peer-reviewed journals. Dr. O'Halloran has been an invited chair and invited speaker at several major electromagnetics and translational medicine conferences/seminars. He is currently a non-executive director of the BioInnovate program and co-lead of the Health Innovation Hub Ireland at NUI Galway.